Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Stereotactic Body Radiotherapy Boost for Unfavorable Localized Prostate Cancer

NCT02016248 is registered in ClinicalTrials.gov with MemorialCare Health System as lead sponsor.

NCT NCT02016248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02016248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Stereotactic Body Radiotherapy Boost for Unfavorable Localized Prostate Cancer
Lead sponsor
MemorialCare Health System
Phase
Not applicable
Overall status
Recruiting
Start date
June 30, 2012
Completion date
June 30, 2029
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer